Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Cristina Alexandra Ciocan"'
Autor:
Cristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, Roxana Cojocneanu, Laura-Ancuta Pop, Alin Moldovan, Cristian Moldovan, Alina Andreea Zimta, Lajos Raduly, Cecilia Pop-Bica, Mihail Buse, Liviuta Budisan, Piroska Virag, Alexandru Irimie, Sandra Martha Gomez Diaz, Ioana Berindan-Neagoe, Cornelia Braicu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-16 (2020)
Abstract Background Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and an unfavorable prognosis rate. Due to the lack of surface receptors, TNBC must be intensely investigated in order to establish a suitable
Externí odkaz:
https://doaj.org/article/b633a0fb286c48bcb13cfb56b00966e9
Autor:
Ancuta Jurj, Laura-Ancuta Pop, Oana Zanoaga, Cristina Alexandra Ciocan-Cârtiţă, Roxana Cojocneanu, Cristian Moldovan, Lajos Raduly, Cecilia Pop-Bica, Monica Trif, Alexandru Irimie, Ioana Berindan-Neagoe, Cornelia Braicu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 54, Iss 4, Pp 648-664 (2020)
Externí odkaz:
https://doaj.org/article/349908bd71cf488b958b5e03dd6322c2
Autor:
Marina Dudea-Simon, Dan Mihu, Laura Ancuta Pop, Razvan Ciortea, Andrei Mihai Malutan, Doru Diculescu, Cristina Alexandra Ciocan, Roxana Maria Cojocneanu, Vasile Simon, Carmen Bucuri, Radu Mocan-Hognogi, Cornelia Braicu, Ioana Berindan-Neagoe
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 11, p 6054 (2022)
Background: Cervical cancer is one of the most common malignancies in women in terms of prevalence and mortality. Cervical cancer has some particularities that distinguish it from any other oncologic pathology: first, it is completely preventable by
Externí odkaz:
https://doaj.org/article/c4ee69286b0e4997a7a257494fd79627
Autor:
Cristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, Roxana Cojocneanu, Laura-Ancuta Pop, Alin Moldovan, Cristian Moldovan, Alina Andreea Zimta, Lajos Raduly, Cecilia Pop-Bica, Mihail Buse, Liviuta Budisan, Piroska Virag, Alexandru Irimie, Sandra Martha Gomes Dias, Ioana Berindan-Neagoe, Cornelia Braicu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/95fe0e4030df4f9080b760d96324f7a2
Autor:
Cristina Alexandra Ciocan-Cartita, Ancuța Jurj, Mihail Buse, Diana Gulei, Cornelia Braicu, Lajos Raduly, Roxana Cojocneanu, Lavinia Lorena Pruteanu, Cristina Adela Iuga, Ovidiu Coza, Ioana Berindan-Neagoe
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 10, p 2576 (2019)
Mass spectrometry (MS) is an essential analytical technology on which the emerging omics domains; such as genomics; transcriptomics; proteomics and metabolomics; are based. This quantifiable technique allows for the identification of thousands of pro
Externí odkaz:
https://doaj.org/article/f965883d2c594e86bc386dd016d444d1
Autor:
Ioana Berindan-Neagoe, Laura Pop, Valentina Pileczki, Liviuţa Budişan, Roxana Cojocneanu, Cornelia Braicu, Ancuţa Jurj, Cristina Alexandra Ciocan-Cȃrtiţă, Alin Moldovan, Lajos Raduly, Schuyler S. Korban
Publikováno v:
Molecular and Cellular Biochemistry. 475:285-299
Triple-negative breast cancer (TNBC), which accounts for 10-20% of all breast cancers, has the worst prognosis. Although chemotherapy treatment is a standard for TNBC, it lacks a specific target. Therefore, new therapeutic strategies are required to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278eaa45a5fe494486c10a0a53d641d2
https://doi.org/10.1007/s11010-020-03881-w
https://doi.org/10.1007/s11010-020-03881-w
Autor:
Cecilia Pop-Bica, Cristina Alexandra Ciocan, Cornelia Braicu, Antonia Haranguș, Marioara Simon, Andreea Nutu, Laura Ancuta Pop, Ondrej Slaby, Atanas G. Atanasov, Radu Pirlog, Nadim Al Hajjar, Ioana Berindan-Neagoe
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 3; Pages: 453
Background: Lung cancer remains one of the most diagnosed malignancies, being the second most diagnosed cancer, while still being the leading cause of cancer-related deaths. Late diagnosis remains a problem, alongside the high mutational burden encou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff83b233fa349ad435e70330d2a18016
https://phaidra.univie.ac.at/o:1675041
https://phaidra.univie.ac.at/o:1675041
Autor:
Ioana Berindan-Neagoe, Cornelia Braicu, Cristina Alexandra Ciocan-Cartita, Monica Trif, Carmen Crivii, Oana Zanoaga, Cristina Stefan, Calin Ionescu, Lajos Raduly, Mihai-Stefan Muresan, Nadim Al Hajjar, Constantin Ioan Busuioc, Simona Mǎrgǎrit
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 476, p 476 (2021)
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 476, p 476 (2021)
Colon adenocarcinoma (COAD) remains an important cause of cancer-related mortality worldwide. Epithelial–mesenchymal transition (EMT) is a key mechanism, promoting not only the invasive or metastatic phenotype but also resistance to therapy. Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430eaaf5a8dfc7c77ffecc3ef165268d
Autor:
Cecilia Pop-Bica, Piroska Virag, Mihail Buse, Cristian Moldovan, Alexandru Irimie, Sandra Martha Gomes Dias, Oana Zanoaga, Ancuta Jurj, Cornelia Braicu, Laura-Ancuta Pop, Alin Moldovan, Cristina Alexandra Ciocan-Cartita, Liviuta Budisan, Roxana Cojocneanu, Ioana Berindan-Neagoe, Lajos Raduly, Alina-Andreea Zimta
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-1 (2020)
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-1 (2020)
Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and an unfavorable prognosis rate. Due to the lack of surface receptors, TNBC must be intensely investigated in order to establish a suitable treatment for patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6086b0d4314a01f49fdbb7cc9299846b
http://europepmc.org/articles/PMC7745496
http://europepmc.org/articles/PMC7745496
Autor:
Cristian Moldovan, Sandra Martha Gomes Dias, Roxana Cojocneanu, Mihail Buse, Oana Zanoaga, Ioana Berindan-Neagoe, Piroska Virag, Laura-Ancuta Pop, Alexandru Irimie, Liviuta Budisan, Cecilia Pop-Bica, Ancuta Jurj, Cornelia Braicu, Cristina Alexandra Ciocan-Cartita, Alin Moldovan, Alina-Andreea Zimta, Lajos Raduly
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-16 (2020)
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-16 (2020)
Background Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and an unfavorable prognosis rate. Due to the lack of surface receptors, TNBC must be intensely investigated in order to establish a suitable treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172b1ff9c31edca99dd1787d08909525
http://europepmc.org/articles/PMC7664031
http://europepmc.org/articles/PMC7664031